The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age
Phase of Trial: Phase III
Latest Information Update: 26 Dec 2016
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar I disorders
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2012 Planned end date changed from 1 Feb 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 17 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.